In this talk I will discuss how we and others have used viral dynamic models to predict the antiviral efficacy of candidate treatments against SARS-CoV-2, and optimize their use. I will discuss how in vitro and data from Non-Human Primates have also been used to elaborate more sophisticated models that integrate the immune response to characterize the interaction between the host, the pathogen and the treatments. I will conclude on how modelers can learn from this outbreak to improve the use and the dissemination of their models in a context of public health crisis.
understand the basics of viral dynamics
understand how it can be usefool tool to understand virus pathogenesis
understand how it can be used to evaluate antiviral treatment